A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma

Ophthalmology

Volumn 106, Issue 3, 1999, Pages 550-555

  Mastropasqua, Leonardo ^a,b   Carpineto, Paolo ^a   Ciancaglini, Marco ^a   Gallenga, Pier E ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL;

AQUEOUS HUMOR FLOW; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FOLLOW UP; GLAUCOMA; HEART RATE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TONOMETER;

EID: 0033497559     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90115-X     Document Type: Article

References (15)

1. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297-304.
2. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 1993;111:1351-8.
3. Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology 1996;103:126-37.
4. Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology 1996;103:138-47.
5. Lindén C, Nuija E, Alm A. Effects on IOP restoration and blood-aqueous barrier after long term treatment with latanoprost in open angle glaucoma and ocular hypertension. Br J Ophthalmol 1997;81:370-2.
6. Sugar HS. Pigmentary glaucoma. A 25-year review. Am J Ophthalmol 1966;62:499-507.
7. Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol 1979;97:1667-72.
8. Richardson TM. Pigmentary Glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: Mosby, 1989; v. 2, chap. 55.
9. Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. The Scandinavian Latanoprost Study Group. Ophthalmology 1995; 102:1743-52.
10. Friström B. A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension. Acta Ophthalmol Scand 1996;74:140-4.
11. Mishima HK, Masuda K, Kitazawa Y, et al. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 1996;114:929-32.
12. Mastropasqua L, Ciancaglini M, Carpineto P, Gallenga PE. Early stadiation of pigmentary dispersion syndrome and long-term analysis of progression to pigmentary glaucoma. Ann Ophthalmol 1996;28:301-7.
13. Palmberg P. Gonioscopy. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: Mosby, 1989; v. 1, chap. 18.
14. Demailly P. Glaucome pigmentaire et glaucome du syndrome exfoliatif. J Fr Ophthalmol 1980;3:523-33.
15. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997;124:544-7.